Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Opportunities and priorities for breast surgical research.

Cutress RI, McIntosh SA, Potter S, Goyal A, Kirwan CC, Harvey J, Francis A, Carmichael AR, Vidya R, Vaidya JS, Fairbrother P, Benson JR, Reed MWR; Association of Breast Surgery Surgical Gap Analysis Working Group.

Lancet Oncol. 2018 Oct;19(10):e521-e533. doi: 10.1016/S1470-2045(18)30511-4. Epub 2018 Oct 1. Review.

PMID:
30303126
2.

Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers.

Winters ZE, Horsnell J, Elvers KT, Maxwell AJ, Jones LJ, Shaaban AM, Schmid P, Williams NR, Beswick A, Greenwood R, Ingram JC, Saunders C, Vaidya JS, Esserman L, Jatoi I, Brunt AM.

BJS Open. 2018 May 22;2(4):162-174. doi: 10.1002/bjs5.53. eCollection 2018 Aug. Review.

3.

Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial.

Corica T, Nowak AK, Saunders CM, Bulsara MK, Taylor M, Williams NR, Keshtgar M, Joseph DJ, Vaidya JS.

Radiat Oncol. 2018 Apr 13;13(1):68. doi: 10.1186/s13014-018-0998-x.

4.

Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy.

Vaidya JS, Wenz F, Tobias JS.

BMJ Evid Based Med. 2018 Feb;23(1):38-39. doi: 10.1136/ebmed-2017-110849. Review. No abstract available.

PMID:
29367327
5.

Rethinking neoadjuvant chemotherapy for breast cancer.

Vaidya JS, Massarut S, Vaidya HJ, Alexander EC, Richards T, Caris JA, Sirohi B, Tobias JS.

BMJ. 2018 Jan 11;360:j5913. doi: 10.1136/bmj.j5913. No abstract available.

PMID:
29326104
6.

Targeted radiotherapy for early breast cancer.

Vaidya JS, Bulsara M, Wenz F, Tobias JS, Joseph D, Baum M.

Lancet. 2018 Jan 6;391(10115):26-27. doi: 10.1016/S0140-6736(17)33316-0. No abstract available.

PMID:
29323648
7.

Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy.

Vaidya JS, Tobias JS.

Breast Care (Basel). 2017 Oct;12(5):314-316. doi: 10.1159/000479726. Epub 2017 Oct 27. No abstract available.

8.

Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.

Vaidya A, Vaidya P, Both B, Brew-Graves C, Bulsara M, Vaidya JS.

BMJ Open. 2017 Aug 17;7(8):e014944. doi: 10.1136/bmjopen-2016-014944.

9.

Commentary on "Accelerated partial breast irradiation consensus statement: Update of an ASTRO Evidence-Based Consensus Statement".

Small W Jr, Thomas TO, Alvarado M, Baum M, Bulsara M, Diaz R, Donnelly E, Feldman S, Grobmyer S, Hoefer R, Joseph D, Kang S, Laronga C, McKee A, Rosen B, Tobias J, Uhl V, Vaidya JS, Wenz F, Holmes D.

Pract Radiat Oncol. 2017 May - Jun;7(3):e159-e163. doi: 10.1016/j.prro.2017.01.016. Epub 2017 Feb 9. No abstract available.

PMID:
28363492
10.

Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.

Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching PA, Untch M, Bulsara M, Vaidya JS, Liedtke C.

Rev Recent Clin Trials. 2017;12(2):93-100. doi: 10.2174/1574887112666170201142458.

PMID:
28155607
11.

Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.

Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching PA, Untch M, Liedtke C, Bulsara M, Vaidya JS.

Strahlenther Onkol. 2017 Jan;193(1):62-69. doi: 10.1007/s00066-016-1072-y. Epub 2016 Nov 17.

PMID:
27858093
12.

Primary diffuse leptomeningeal oligodendrogliomatosis: A case report and literature review.

Chellathurai A, Vaidya JS, Kathirvelu G, Alagappan P.

Indian J Radiol Imaging. 2016 Jul-Sep;26(3):337-341.

13.

An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).

Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Saunders C, Brew-Graves C, Potyka I, Morris S, Vaidya HJ, Williams NR, Baum M.

Health Technol Assess. 2016 Sep;20(73):1-188.

14.

In Reply to Park et al.

Vaidya JS, Bulsara M, Wenz F, Coombs N, Singer J, Ebbs S, Massarut S, Saunders C, Douek M, Williams N, Joseph D, Tobias JS, Baum M.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):707-8. doi: 10.1016/j.ijrobp.2016.06.2461. No abstract available.

PMID:
27681769
15.

Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial.

Corica T, Nowak AK, Saunders CM, Bulsara M, Taylor M, Vaidya JS, Baum M, Joseph DJ.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):55-64. doi: 10.1016/j.ijrobp.2016.04.024. Epub 2016 Apr 23.

16.

Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials.

Vaidya JS, Bulsara M, Wenz F, Coombs N, Singer J, Ebbs S, Massarut S, Saunders C, Douek M, Williams NR, Joseph D, Tobias JS, Baum M.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):259-265. doi: 10.1016/j.ijrobp.2016.05.008. Epub 2016 May 13. Review.

17.

Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.

Coombs NJ, Coombs JM, Vaidya UJ, Singer J, Bulsara M, Tobias JS, Wenz F, Joseph DJ, Brown DA, Rainsbury R, Davidson T, Adamson DJ, Massarut S, Morgan D, Potyka I, Corica T, Falzon M, Williams N, Baum M, Vaidya JS.

BMJ Open. 2016 May 9;6(5):e010703. doi: 10.1136/bmjopen-2015-010703.

18.

Partial breast irradiation and the GEC-ESTRO trial.

Vaidya JS, Bulsara M, Wenz F, Tobias JS, Joseph D, Baum M.

Lancet. 2016 Apr 23;387(10029):1717. doi: 10.1016/S0140-6736(16)30255-0. No abstract available. Erratum in: Lancet. 2016 May 7;387(10031):1908.

PMID:
27116272
19.

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Fabris L, Berton S, Citron F, D'Andrea S, Segatto I, Nicoloso MS, Massarut S, Armenia J, Zafarana G, Rossi S, Ivan C, Perin T, Vaidya JS, Avanzo M, Roncadin M, Schiappacassi M, Bristow RG, Calin G, Baldassarre G, Belletti B.

Oncogene. 2016 Sep 15;35(37):4914-26. doi: 10.1038/onc.2016.23. Epub 2016 Feb 15.

20.

Accelerated Partial Breast Irradiation in Clinical Practice.

Wenz F, Sedlmayer F, Herskind C, Welzel G, Sperk E, Neumaier C, Gauter-Fleckenstein B, Vaidya JS, Sütterlin M.

Breast Care (Basel). 2015 Aug;10(4):247-52. doi: 10.1159/000437194. Epub 2015 Jul 15. Review.

Supplemental Content

Loading ...
Support Center